LENZ Therapeutics, Inc. (LENZ) Revenue (2025 - 2026)

LENZ Therapeutics (LENZ) posted quarterly Revenue of $1.9 million for Q1 2026, up 115.21% sequentially from -$12.5 million in Q4 2025.

LENZ Therapeutics, Inc. (LENZ) Revenue (2025 - 2026) Analysis & Trends

LENZ Therapeutics has disclosed Revenue across 2 years of filings, most recently posting $1.9 million for Q1 2026.

  • In Q1 2026, Revenue changed N/A year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $6.9 million (changed N/A YoY), while the FY2025 annual figure was $5.0 million, changed N/A from the prior year.
  • Revenue advanced to $1.9 million in Q1 2026, from -$12.5 million in the prior quarter.
  • Over the last five years, Revenue for LENZ reached as high as $12.5 million in Q3 2025 and fell as low as -$12.5 million in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 1.90 Mn
Dec 31, 2025 -12.50 Mn
Sep 30, 2025 12.50 Mn
Jun 30, 2025 5.00 Mn